HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

SQPKTACNKCYCKRC Tat(16-30) human epitope
        NCYCKRCCF Tat(24-32) A*29:02 human epitope
        kCYCKRCCF Tat(24-32) escape documented in this paper
        NCYCKkCCF Tat(24-32) observed variant
        tCYCKRCCF Tat(24-32) observed variant
        kCYCKsCCF Tat(24-32) observed variant
        kCYCKkCCF Tat(24-32) observed variant
        NCYCKkCCy Tat(24-32) susceptible form
        NCYCKKCCY Tat(24-32) A*29:02 human epitope
        kCYCKKCCY Tat(24-32) escape documented in this paper
        kCYCKrCCY Tat(24-32) escape documented in this paper
        kCYCKqCCY Tat(24-32) escape documented in this paper
        NCYCKKyCY Tat(24-32) observed variant
        NCYCKKCCc Tat(24-32) observed variant
        NCYCKrCCf Tat(24-32) susceptible form
        NCYCKQCCF Tat(24-32) A*32:01 human epitope
        NCYCKKCCF Tat(24-32) human epitope
        NCYCKHCSY Tat(24-32) human epitope
             KCCFHCQVCFTTKGL Tat(29-43) human epitope
              CCFHCQVC Tat(30-37) B*18 human epitope
              CCFHCQVC Tat(30-37) C*07 human epitope
              CCFHCQVC Tat(30-37) C*12 human epitope
              CCFHCQVC Tat(30-37) C*12 human epitope
              CCmHCQVC Tat(30-37) susceptible form
              CCFHCQVC Tat(30-37) C*12 human epitope
              CCFHCQVC Tat(30-37) C*12 epitope
              CCFHCQVC Tat(30-37) C*12 human epitope
              CCFHCQVC Tat(30-37) C*12 human epitope
              CCFHCQVC Tat(30-37) C*12:03 human epitope
              CCFHCQsC Tat(30-37) escape documented in this paper
              CClHCQVC Tat(30-37) escape documented in this paper
              CCFHCQVC Tat(30-37) C*12:03 human epitope
              CClHCQVC Tat(30-37) escape documented in this paper
              CCFHCQsC Tat(30-37) escape documented in this paper
              CCFHCQVC Tat(30-37) C*12:03 human epitope
              CCFHCQVC Tat(30-37) C*12:03 human epitope
              CClHCQVC Tat(30-37) escape documented in this paper
              CCFHCQsC Tat(30-37) escape documented in this paper
              CCFHCQVC Tat(30-37) C*12:03 human epitope
              CCFHCQVC Tat(30-37) C*12:03 human epitope
              CCFHCQVC Tat(30-37) human epitope
               CLHCQVCFI Tat(31-39) A2 human epitope
               CfHCQVCFI Tat(31-39) observed variant
               CFHCQVCFITKGLGISYGRK Tat(31-50) human epitope
               HCQVCFIsKGLGISYGRK Tat(31-50) observed variant
                FHCQVCFMTK Tat(32-41) human epitope
                FHCQVCFMkK Tat(32-41) observed variant
                FHCQVCFMiK Tat(32-41) observed variant
                lHCQVCFMkK Tat(32-41) observed variant
                FHCQVCFiTK Tat(32-41) observed variant
                lHCQVCFMTK Tat(32-41) observed variant
                FnCQVCFMTK Tat(32-41) observed variant
                FHCQdCFMkK Tat(32-41) observed variant
                FHCQVyFMTK Tat(32-41) observed variant
                kHCQVCFMlK Tat(32-41) escape documented in this paper
                FHCQVCFtTK Tat(32-41) escape documented in this paper
                FHCQVCFITK Tat(32-41) human epitope
                FHCQVCFMTK Tat(32-41) human epitope
                FHCQVCFtTK Tat(32-41) escape documented in this paper
                FHCQVCFtTe Tat(32-41) observed variant
                lHCQVCFMkK Tat(32-41) escape documented in this paper
                YHCLVCFQTKGLGISYGR Tat(32-49) C*02 human epitope
                YHCLVCFQTKGLGISYGR Tat(32-49) C*02 human epitope
                FHCQVCFTTKGLGISYGR Tat(32-49) human epitope
                 HCQVCFISKGLGISYGRK Tat(33-50) human epitope
                 CFHCQVCFItKGLGISYGRK Tat(33-50) observed variant
                 HCQVCFISKGLGIpYGRK Tat(33-50) observed variant
                 HCQVCFISKGLGIn-GRK Tat(33-50) observed variant
                 HCQVCFISKGLGIS-GRK Tat(33-50) observed variant
                 HCQVCFITKGLGISYGRK Tat(33-50) human epitope
                    VCFTTKGLGI Tat(36-45) B*15 human epitope
                    VCFMTKGLGI Tat(36-45) B*15:01 human epitope
                    VCFtTKGLGI Tat(36-45) escape documented in this paper
                    VCFtTeGLGI Tat(36-45) observed variant
                    VCFMkKGLGI Tat(36-45) escape documented in this paper
                    VCFITKALGI Tat(36-45) human epitope
                    VCFMTKGLGI Tat(36-45) human epitope
                    VCFMkKGLGI Tat(36-45) observed variant
                    VCFMTKGLGv Tat(36-45) observed variant
                    VCFMTKGLsI Tat(36-45) observed variant
                    dCFMkKGLGI Tat(36-45) observed variant
                    VCFiTKGLGI Tat(36-45) observed variant
                    VyFMTKGLGI Tat(36-45) observed variant
                    VCFMiKGLGI Tat(36-45) observed variant
                    VCFMlKGLGI Tat(36-45) escape documented in this paper
                    VCFtTKGLGI Tat(36-45) escape documented in this paper
                    VCFQTKGLGISYGRK Tat(36-50) human epitope
                    VCFQTKGLGISYGRK Tat(36-50) human epitope
                    VCFTTKALGISYGRKKR Tat(36-52) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health